Stay updated on Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.

Latest updates to the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new publication citation was added to the Publications section, referencing a 2026 Nat Commun article on spatial predictors of response to chemo-immunotherapy in MSS metastatic colorectal cancer. This update broadens the scholarly context available for the MAYA study.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page’s displayed software revision/version changed from v3.5.2 to v3.5.3, reflecting an update to the site template or backend release rather than the underlying study details.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check62 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.2 was added. The previous funding-lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.